WHAT WE DO

The issue

The threat to human and economic development posed by the growing burden of cancer in low- and middle-income countries is widely recognized. Cancer is now one of the leading causes of morbidity and mortality worldwide, with an estimated 14.1 million new cases and 8.2 million deaths in 2008.

With over 8 million of these new cases and 5 million of the deaths, the developing world is bearing over half of this burden, but is the least equipped to cope with this situation. Cancer in developing countries is also more likely to be diagnosed at a later stage and, therefore, be less responsive to treatment.

These global figures are made possible by the work of population-based cancer registries, which provide the means of estimating the burden of cancer in different communities.

Cancer registry data also indicate that the situation is likely to get worse in the future due to the increase in the global population and as an effect of ageing: it is predicted that by 2030 the number of new cancer cases will increase to 21.7 million, and deaths to 13 million (GLOBOCAN 2008). The proportion of these occurring in developing countries will also gradually increase over time. In the absence of cancer planning and control interventions, around 70% of the global cancer burden will arise in such areas of the world.



GICR is endorsed by

American Cancer Society African Organisation for Research and Training in Cancer Centers for Disease Control and Prevention Dutch Cancer Society European Network of Cancer Registries International Association of Cancer Registries IAEA Programme of Action for Cancer Therapy International Network for Cancer Treatment and Prevention North American Association of Central Cancer Registries NCI Center for Global Health Pan American Health Organization Red de Institutos Nacionales de Cancer Tata Memorial Center Union for International Cancer Control World Health Organization
Admin login